Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Covington
QuintilesIMS
Johnson and Johnson
Daiichi Sankyo
Cantor Fitzgerald
Federal Trade Commission
Medtronic
Dow

Generated: April 27, 2018

DrugPatentWatch Database Preview

NALBUPHINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Nalbuphine Hydrochloride, and what generic alternatives are available?

Nalbuphine Hydrochloride is a drug marketed by Abbott, Abbvie, Barr, Hospira, and Igi Labs Inc. and is included in thirteen NDAs.

The generic ingredient in NALBUPHINE HYDROCHLORIDE is nalbuphine hydrochloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the nalbuphine hydrochloride profile page.
Drug patent expirations by year for NALBUPHINE HYDROCHLORIDE
Pharmacology for NALBUPHINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for NALBUPHINE HYDROCHLORIDE
Synonyms for NALBUPHINE HYDROCHLORIDE
(4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol;hydrochloride
(5alpha,6alpha)-17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol hydrochloride
17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol hydrochloride hydrate
17-(Cyclobutylmethyl)-4,5alpha-epoxymorphinan-3,6alpha,14-triol hydrochloride
20594-83-6 (Parent)
23277-43-2
API0003485
C21H27NO4.HCl
C21H32ClNO6
CCG-220118
CHEBI:7455
CHEMBL1201132
D00843
D06ZXH
DTXSID20177844
EINECS 245-549-9
En 2234A
EN-2234A
HMS1568G18
LS-92174
MLS002154202
Morphinan-3,6-alpha,14-triol, 17-(cyclobutylmethyl)-4,5-alpha-epoxy-, hydrochloride
Morphinan-3,6,14-triol, 17-(cyclobutylmethyl)-4,5-epoxy-, hydrochloride, (5-alpha,6-alpha)-
Morphinan-3,6,14-triol, 17-(cyclobutylmethyl)-4,5-epoxy-, hydrochloride, (5alpha,6alpha)-
N-Cyclobutylmethyl-14-hydroxydihydronormorphine hydrochloride
Nalbufina clorhidrato [Spanish]
Nalbuphine HCL
Nalbuphine hydrochloride (USAN)
Nalbuphine hydrochloride [USAN]
NALBUPHINEHYDROCHLORIDE
Nubain
Nubain (TN)
PHN-131
Prestwick_344
PW-4142
SCHEMBL41123
SMR001233488
UNII-ZU4275277R
V1613
YZLZPSJXMWGIFH-BCXQGASESA-N
ZU4275277R

US Patents and Regulatory Information for NALBUPHINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 070917-001 Feb 3, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 070916-001 Feb 3, 1989 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Barr NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 074471-002 Mar 19, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Igi Labs Inc NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 072073-001 Apr 10, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Farmers Insurance
Boehringer Ingelheim
Moodys
Argus Health
US Army
Chubb
Fish and Richardson
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.